MYIDYL Drug Patent Profile
✉ Email this page to a colleague
When do Myidyl patents expire, and what generic alternatives are available?
Myidyl is a drug marketed by Usl Pharma and is included in one NDA.
The generic ingredient in MYIDYL is triprolidine hydrochloride. There are thirteen drug master file entries for this compound. Additional details are available on the triprolidine hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MYIDYL?
- What are the global sales for MYIDYL?
- What is Average Wholesale Price for MYIDYL?
Summary for MYIDYL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 33 |
| Patent Applications: | 4,489 |
| DailyMed Link: | MYIDYL at DailyMed |
US Patents and Regulatory Information for MYIDYL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Usl Pharma | MYIDYL | triprolidine hydrochloride | SYRUP;ORAL | 087963-001 | Jan 18, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
